Stress and the skin

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 2, 2010, Pages 213-220

  Reich, A ^a   Wojcik Maciejewicz A ^a   Slominski, A T ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Mast cells; Skin diseases; Stress, psychological

Indexed keywords

BETA ENDORPHIN; BRADYKININ; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOKINE; NERVE GROWTH FACTOR; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALOPECIA AREATA; ATOPIC DERMATITIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; DISEASE EXACERBATION; EMOTIONAL STRESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; LICHEN PLANUS; MAST CELL; MENTAL STRESS; NERVE ENDING; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRURITUS; PSORIASIS; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SENSORY NERVE; SKIN CELL; SKIN INFLAMMATION; URTICARIA;

EID: 77954474755     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Quan XJ, Hassan BA. From skin to nerve: flies, vertebrates and the first helix. Cell Mol Life Sci 2005;62:2036-49.
2. Boulos MNK. The skin and the psyche: a literature overview [Internet]. Available from: http://www.medicad.com/ [cited 2010, Feb 12].
3. Katsarou-Katsari A, Filippou A, Theoharides TC. Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int J Immunopathol Pharmacol 1999;12:7-11. (Pubitemid 29178891)
4. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine Rev 2000;21:457-87.
5. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020. (Pubitemid 30452009)
6. Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/ melatoninergic system: securing a place under the sun. Faseb J 2005;19:176-94. (Pubitemid 40189259)
7. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006;27:32-9.
8. Nordlind K, Azmitia EC, Slominski A. The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 2008;17:301-11. (Pubitemid 351338673)
9. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12.
10. Scholzen TE, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune system. Exp Dermatol 1998;7:81-96.
11. Luger T, Paus R, Slominski A, Lipton J. The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview. Ann N Y Acad Sci 1999;885:11-4.
12. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006;126:1697-704. (Pubitemid 44086503)
13. Selye H. A syndrome produced by various noxious agents. Nature London 1936;138:32-3.
14. Seyle H. The stress of life (rev. ed.). New York: McGraw-Hill Book Company; 1976.
15. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213:1394-7.
16. Spiess J, Rivier J, Rivier C, Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Nad Acad Sci U S A 1981;78:6517-21.
17. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
18. Chrousos GP. The Hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-63.
19. Slominski A, Paus R, Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 1993;93:C1-6.
20. Slominski A, Ermak G, Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab 1996;81:2746-9.
21. Slominski A, Mihm MC. Potential mechanism of skin response to stress. Int J Dermatol 1996;35:849-51. (Pubitemid 26426633)
22. Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J. CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol 2005;162:97-102. (Pubitemid 40503103)
23. Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 2005;288:E701-6.
24. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary- adrenal axis and synthesize cortisol. FASEB J 2005;19:1332-4. (Pubitemid 41113740)
25. Rousseau K, Kauser S, Pritchard LE, Warhurst A, Oliver RL, Slominski A et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 2007;21:1844-56. (Pubitemid 46855630)
26. Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 2007;265-266:143-9.
27. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE et al. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001;15:1678-93. (Pubitemid 32730215)
28. Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J et al. Corticotropin releasing hormone and the skin. Front Biosci 2006;11:2230-48.
29. Slominski A, Zbytek B, Szczesniewski A, Wortsman J. Cultured human dermal fibroblasts do produce Cortisol. J Invest Dermatol 2006;126:1177-8.
30. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J et al. Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci 1999;885: 287-311.
31. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J. Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 1998;83:1020-4.
32. Slominski A, Szczesniewski A, Wortsman J: Liquid chromatographymass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab 2000;85:3582-8.
33. Zouboulis CC, Seitmann H, Hiroi N, Chen W, Young M, Oeff M et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A 2002;99:7148-53.
34. Ito N, Ito T, Bettennan A, Paus R. The human hair bulb is a source and target of CRH. J Invest Dermatol 2004;122:235-7. (Pubitemid 38114662)
35. Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J. CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 2006;206:780-91. (Pubitemid 43191053)
36. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 2004;145:941-50. (Pubitemid 38183838)
37. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 2007;39:166-70. (Pubitemid 46535575)
38. Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J et al. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In vitro Cell Dev Biol Anim 2000;36:211-6. (Pubitemid 30193770)
39. Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J. Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In vitro Cell Dev Biol Anim 2001;37:50-4.
40. Zbytek B, Slominski AT. Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol 2005;203:118-26. (Pubitemid 40328178)
41. Zbytek B, Pikula M, Slominski RM, Mysliwski A, Wei E, Wortsman J et al. Corticotropinreleasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol 2005;152:474-80. (Pubitemid 40547121)
42. O'Kane M, Murphy EP, Kirby B. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol 2006;15:143-53.
43. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004;25:563-8. (Pubitemid 39371146)
44. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madnappan B et al. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 2004;145:43-8. (Pubitemid 38094499)
45. Zbytek B, Mysliwski A, Slominski A, Wortsman J, Wei ET, Mysliwska J. Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci 2002;70:1013-21. (Pubitemid 34085093)
46. Park HJ, Kim HJ, Lee JY, Cho BK, Gallo RL, Cho DH. Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes. J Invest Dermatol 2007;127: 1210-6.
47. Ito N, Sugawara K, Bodó E, Takigawa M, van Beek N, Ito T et al. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010;130:995-1004.
48. Zbytek B, Slominski AT. CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol 2007;127:730-2. (Pubitemid 46271043)
49. Slominski A. On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol 2009;160:229-32.
50. Kim JE, Cho DH, Kim HS, Kim HJ, Lee JY, Cho BK et al. Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis. Exp Dermatol 2007;16: 104-9.
51. Tagen M, Stiles L, Kalogeromitros D, Gregoriou S, Kempuraj D, Makris M et al. Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol 2007;127:1789-91.
52. Zhou C, Yu X, Cai D, Liu C, Li C. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis. Med Hypotheses 2009;73:513-5.
53. Kim HS, Cho DH, Kim HJ, Lee JY, Cho BK, Park HJ. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata. Exp Dermatol 2006;15:515-22.
54. Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, McElwee KJ. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009;129: 1527-38.
55. Carlson KW, Nawy SS, Wei ET, Sadée W, Filov VA, Rezsova VV et al. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res 2001;21:1173-9.
56. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004;84:1155-228.
57. Kim MH, Cho D, Kim HJ, Chong SJ, Lee KH, Yu DS et al. Investigation of the corticotropin-releasing hormone-proopiomelanocortin axis in various skin tumours. Br J Dermatol 2006;155: 910-5.
58. Yang Y, Park H, Yang Y, Kim TS, Bang SI, Cho D. Enhancement of cell migration by corticotropin-releasing hormone through ERK1/2 pathway in murine melanoma cell line, B 16F10. Exp Dermatol 2007;16:22-7.
59. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997;137: 843-50.
60. Peters EM, Kuhlmei A, Tobin DJ, Muller-Rover S, Klapp BF, Arck PC. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005;19: 252-62. (Pubitemid 40431540)
61. Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Br J Dermatol 2006;154:876-82.
62. Reich A, Szepietowski JC. Vasoactive peptides in the pathogenesis of psoriasis. G Ital Dermatol Venereol 2008;143:289-98.
63. Johansson O. Morphological characterization of the somatostatin- immunoreactive dendritic cells in urticaria pigmentosa patients by computerized image analysis. Scand J Immunol 1985;21:431-9.
64. Johansson O, Nordlind K: Immunoreactivity to material like vasoactive intestinal polypeptide in epidermal cells of lichen sclerosus et atrophicus. Am J Dermatopathol 1986;8:105-8. (Pubitemid 17045834)
65. Kürkcüoglu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol 1991;25:725-6.
66. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuronal marker and neuropeptide studies in vitiligo. Br J Dermatol 1994;131:160-5.
67. Al'Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuronal marker and neuropeptide studies in nodular prurigo. Eur J Dermatol 1994;4:154.
68. Hagforsen E, Nordlind K, Michaëlson G. Skin nerve fibres and their contact with mast cells in patients with palmoplantar pustulosis. Arch Dermatol Res 2000;292:269-74. (Pubitemid 30386435)
69. Reich A, Szepietowski J. The role of selected neuropeptides in neurogenic inflammation of the skin. Dermatol Klin 2006;8:103-7.
70. Kalish RS. Clues from alopecia areata on the role of neuropeptides in the initiation of autoimmunity. J Invest Dermatol 2007;127: 1289-91.
71. Reich A, Orda A, WiÊnicka B, Szepietowski JC. Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp Dermatol 2007;16:421-8. (Pubitemid 46585370)
72. Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 2008;22: 223-8.
73. Kleyn CE, Schneider L, Saraceno R, Mantovani C, Richards HL, Fortune DG et al. The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol 2008;128:1273-9. (Pubitemid 351543193)
74. Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, Klapp BF et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 2008;128:434-46.
75. Marconi A, Vaschieri C, Zanoli S, Giannetti A, Pincelli C. Nerve growth factor protects human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol 1999;113:920-7. (Pubitemid 30013332)
76. Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A et al. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006;126:1719-27.
77. Botchkarev VA, Botchkareva NV, Peters EM, Paus R. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Progr Brain Res 2004;146:493-513. (Pubitemid 37541401)
78. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA 1994;91:10440-4.
79. Alleva E, Petruzzi S, Cirulli F, Aloe L. NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav 1996;54:65-72.
80. Peters EM, Handjiski M B, Kuhlmei A, Hagen E, Bielas H, Braun A et al. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004;165:259-271.
81. Groneberg DA, Serowka F, Peckenschneider N, Artuc M. Grützkau A, Fischer A et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005;161:87-92.
82. Raap U, Kapp A. Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 2005;5:419-24.
83. Wang IJ, Hsieh WS, Guo YL, Jee SH, Hsieh CJ, Hwang YH et al. Neuro-mediators as predictors of paediatric atopic dermatitis. Clin Exp Allergy 2008;38:1302-8.
84. Denda M, Tsuchiya T, Elias PM, Feingold KR. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 2000;278:R367-72.
85. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 2001;117:309-17. (Pubitemid 34205716)
86. Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR et al. Psychological stress perturbs epidermal permeability barrier homeostasis: Implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001;137:53-9. (Pubitemid 32096358)
87. Ishida H, Mitsui K, Nukaya H, Matsumoto K, Tsuji K. Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice. Biol Pharm Bull 2003;26:170-81.
88. Muizzuddin N, Matsui MS, Marenus KD, Maes DH. Impact of stress of marital dissolution on skin barrier recovery: tape stripping and measurement of trans-epidermal water loss (TEWL). Skin Res Technol 2003;9:34-8. (Pubitemid 36621685)
89. Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005;124:587-95.
90. Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 2007;117:3339-49.
91. Choi EH, Demerjian M, Crumrine D, Brown BE, Mauro T, Elias PM et al. Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol 2006;291:R1657-62.
92. Slominski A. A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest 2007;117:3166-9.
93. Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, Feingold KR. Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech 2008;5:137-44.
94. Gaston L, Lassonde M, Bernier-Buzzanga J, Hodgins S, Crombez JC. Psoriasis and stress: a prospective study. J Am Acad Dermatol 1987; 17:82-6.
95. Gaston L, Crombez JC, Lassonde M, Bernier-Buzzanga J, Hodgins S. Psychological stress and psoriasis: experimental and prospective correlational studies. Acta Derm Venereol Suppl 1991;156:37-43.
96. Harvima IT, Viinamäki H, Naukkarinen A, Paukkonen K, Neittaanmäki H, Harvima RJ et al. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychother Psychosom 1993;60:168-76.
97. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
98. Schmid-Ott G, Jacobs R, Jäger B, Klages S, Wolf J, Werfel T et al. Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary study. Psychother Psychosom 1998;67:37-42.
99. Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ et al. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 2005;153: 1114-20. (Pubitemid 41779564)
100. Buske-Kirschbaum A, Kern S, Ebrecht M, Hellhammer DH. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav Immun 2007;21:92-9. (Pubitemid 44854446)
101. Mastrolonardo M, Alicino D, Zefferino R, Pasquini P, Picardi A. Effect of psychological stress on salivary interleukin-1beta in psoriasis. Arch Med Res 2007;38:206-11. (Pubitemid 46080542)
102. Schmid-Ott G, Jaeger B, Boehm T, Langer K, Stephan M, Raap U et al. Immunological effects of stress in psoriasis. Br J Dermatol 2009; 160:782-5.
103. Schmid-Ott G, Jaeger B, Meyer S, Stephan E, Kapp A, Werfel T. Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J Allergy Clin Immunol 2001;108:455-62. (Pubitemid 32881070)
104. Buske-Kirschbaum A, Ebrecht M, Kern S, Hellhammer DH. Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris) - do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)? Psychoneuroendocrinology 2006;31:439-46.
105. Gil KM, Keefe FJ, Sampson HA, McCaskill CC, Rodin J, Crisson JE. The relation of stress and family environment to atopic dermatitis symptoms in children. J Psychosom Res 1987;31:673-84. (Pubitemid 17167530)
106. Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S et al. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol 1999;104: 173-6. (Pubitemid 29364499)
107. Amano H, Negishi I, Akiyama H, Ishikawa O. Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor. Neuropsychopharmacology 2008;33: 566-73.
108. Buske-Kirschbaum A, Jobst S, Wustmans A, Kirschbaum C, Rauh W, Hellhammer D. Attenuated free Cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom Med 1997;59: 419-26. (Pubitemid 27315244)
109. Buske-Kirschbaum A, Geiben A, Höllig H, Morschhäuser E, Hellhammer D. Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 2002;87:4245-51.
110. Buske-Kirschbaum A, Gierens A, Höllig H, Hellhammer DH. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002;129:161-7. (Pubitemid 34874921)
111. Schmid-Ott G, Jaeger B, Adamek C, Koch H, Lamprecht F, Kapp A et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 2001;107:171-7.
112. Kimata H. Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in patients with atopic dermatitis. Brain Behav Immun 2003;17: 134-8.
113. Edwards AE, Shellow WV, Wright ET, Dignam TF. Pruritic skin diseases, psychological stress, and the itch sensation. A reliable method for the induction of experimental pruritus. Arch Dermatol 1976;112:339-43.
114. Reich A, Szepietowski JC, Wisnicka B, Paean P. Does stress influence itching in psoriatic patients? Dermatol Psychosom 2003;4:151-5.
115. Paus R, Schmelz M, Bíró T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006;116:1174-86.
116. Katz RJ, Roth KA Stress induced grooming in the rat - an endorphin mediated syndrome. Neurosci Lett 1979;13:209-2.
117. Fjellner B, Arnetz BB. Psychological predictors of pruritus during mental stress. Acta Derm Venereol 1985;65:504-8.